The Investigational New Drug (IND) CDMO market is booming, projected to reach $4.45B in 2025 with a 6.55% CAGR. This report analyzes market drivers, trends, restraints, key players (Labcorp, Charles River, Thermo Fisher), and regional data (North America, Europe, Asia). Discover growth opportunities and competitive landscapes in this dynamic industry.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.